Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (åbner nyt vindue)

Barillari G, Pasca S, Barillari A, De Angelis V.

Kilde‎: Blood Transfus 2012;10(1):87-94.

Indekseret‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (åbner nyt vindue)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (åbner nyt vindue)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Kilde‎: Chest 2012;141(2 Suppl):e326S-50S.

Indekseret‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (åbner nyt vindue)

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. (åbner nyt vindue)

Flordal PA.

Kilde‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

Indekseret‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 (åbner nyt vindue)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (åbner nyt vindue)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Kilde‎: Lancet 2015;385(9982):2077-87.

Indekseret‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (åbner nyt vindue)

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. (åbner nyt vindue)

Goodnough LT, Shander A.

Kilde‎: Blood 2011;117(23):6091-9.

Indekseret‎: PubMed 21411756

DOI‎: 10.1182/blood-2010-11-316075

https://www.ncbi.nlm.nih.gov/pubmed/21411756 (åbner nyt vindue)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (åbner nyt vindue)

Hanke AA, Joch C, Görlinger K.

Kilde‎: Br J Anaesth 2013;110(5):764-72.

Indekseret‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (åbner nyt vindue)

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature. (åbner nyt vindue)

Jaben EA, Mulay SB, Stubbs JR.

Kilde‎: J Intensive Care Med 2015;30(1):3-7.

Indekseret‎: PubMed 25492811

DOI‎: 10.1177/0885066613487298

https://www.ncbi.nlm.nih.gov/pubmed/25492811 (åbner nyt vindue)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (åbner nyt vindue)

Levi M, Eerenberg E, Kamphuisen PW.

Kilde‎: J Thromb Haemost 2011;9(9):1705-12.

Indekseret‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (åbner nyt vindue)

Emergency reversal of warfarin anticoagulation. (åbner nyt vindue)

Lin Y, Callum J.

Kilde‎: CMAJ 2010;182(18):2004.

Indekseret‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (åbner nyt vindue)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (åbner nyt vindue)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Kilde‎: Thromb Haemost 2012;108(2):217-24.

Indekseret‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (åbner nyt vindue)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (åbner nyt vindue)

Mo Y, Yam FK.

Kilde‎: Pharmacotherapy 2015;35(2):198-207.

Indekseret‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (åbner nyt vindue)

Idarucizumab for dabigatran reversal - full cohort analysis. (åbner nyt vindue)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Kilde‎: N Engl J Med 2017;377(5):431-41.

Indekseret‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (åbner nyt vindue)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (åbner nyt vindue)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Kilde‎: Anesth Analg 2011;113(4):703-10.

Indekseret‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (åbner nyt vindue)

Oral anticoagulation in surgical procedures: risks and recommendations. (åbner nyt vindue)

Torn M, Rosendaal FR.

Kilde‎: Br J Haematol 2003;123(4):676-82.

Indekseret‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (åbner nyt vindue)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (åbner nyt vindue)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Kilde‎: Blood 2012;119(9):2172-4.

Indekseret‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (åbner nyt vindue)